Skip to main content

Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.50
+0.00 (0.00%)
AAPL  266.43
+0.00 (0.00%)
AMD  258.12
+0.00 (0.00%)
BAC  54.32
+0.00 (0.00%)
GOOG  334.47
+0.00 (0.00%)
META  671.58
+0.00 (0.00%)
MSFT  411.22
+0.00 (0.00%)
NVDA  198.86
+0.00 (0.00%)
ORCL  169.81
+0.00 (0.00%)
TSLA  391.95
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.